Evidence map›Paper›PMID 41059174›Full record

ArticleFrontiers in public health2025

Bridging the regulatory gap: a call for a regional, evidence-informed approach to e-cigarette control in Latin America.

Juan S Izquierdo-Condoy

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Juan S Izquierdo-CondoyOne Health Research Group, Universidad de las Américas, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electronic cigarettes, a subset of electronic nicotine delivery systems (ENDS), have rapidly gained global popularity, with adolescent and young adult uptake emerging as a key public health concern. Promoted as "healthier alternatives" to smoking and often marketed as cessation aids, these devices have not created the anticipated risk-reduction environment and instead threaten to erode hard-won gains in tobacco control. While international experience highlights the potential effectiveness of policies such as taxation, age restrictions, marketing bans, and smoke-free environment laws, results remain heterogeneous and context-dependent, with enforcement playing a critical role. In Latin America, tobacco use declined from 28% in 2000 to 16.3% in 2020 under the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), yet electronic cigarette regulation has lagged, resulting in what can be described as an "unregulated epidemic." Policy responses remain fragmented: some countries enforce comprehensive bans, others apply partial measures, and many still lack specific frameworks, leaving critical gaps in taxation, surveillance, and digital marketing oversight. This regulatory asymmetry facilitates youth-oriented market expansion and the re-normalization of nicotine consumption. Drawing on global lessons, this perspective argues that Latin America must avoid replicating the decades-long delay experienced with tobacco regulation. Instead, the region requires harmonized, evidence-informed, and context-sensitive frameworks that integrate ENDS-specific measures-such as flavor restrictions, comprehensive advertising bans, nicotine caps, and strict control of online sales-supported by robust enforcement and multisectoral coordination. Such an approach offers the best opportunity to contain this unregulated epidemic, safeguard public health, and protect future generations across the region.

Indexed as

Electronic Nicotine Delivery SystemsGovernment RegulationHealth PolicyAdolescentHumansLatin AmericaMarketingYoung Adultelectronic cigarettesLatin Americapublic healthpublic health policyregulatory frameworks

Identifiers

PMID41059174
PMCPMC12497729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.